A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Adeela Kamal(Forma Therapeutics (United States)), Lia Thao(Forma Therapeutics (United States)), John Sensintaffar(Forma Therapeutics (United States)), Lin Zhang(Forma Therapeutics (United States)), Marcus F. Boehm(Forma Therapeutics (United States)), Lawrence C. Fritz(Forma Therapeutics (United States)), Francis Burrows(Forma Therapeutics (United States))
Cited by 1,391
Abstract
Related Papers
In Vivo Function of Hsp90 Is Dependent on ATP Binding and ATP Hydrolysis
Wolfgang M.J. Obermann, Holger Sondermann, Alicia A. Russo et al.|The Journal of Cell Biology|1998|601